… phase 1 study of CTM103, a LNP mRNA encoding an IL2Rβγ selective IL-2v, as monotherapy and in combination with pembrolizumab, in patients with advanced solid …
用户wgPsi57cCaAs
3小时前
21
10
已关闭
DOI:
文献链接:
其他信息:
C Kong, J Zhang, L Sun, Q Xuan, H Huang, K Wang
2024
jitc.bmj.com
… CTM103 stimulated significant and sustained expansion of … Methods This first-in-human, open label phase 1 study … of 3+3 escalation cohorts to define maximum tolerated dose (MTD). If …